We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ATAI Life Sciences NV | NASDAQ:ATAI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.12 | -7.79% | 1.42 | 1.39 | 1.42 | 1.50 | 1.30 | 1.31 | 2,870,217 | 00:54:45 |
The
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
|
|
|
|
(Nasdaq Global Market)
|
Item 7.01 |
Regulation FD Disclosure
|
|
ATAI LIFE SCIENCES N.V.
|
|
Date: September 29, 2023
|
By:
|
/s/ Florian Brand
|
|
Name:
|
Florian Brand
|
|
Title:
|
Chief Executive Officer
|
Document and Entity Information |
Sep. 29, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Sep. 29, 2023 |
Entity File Number | 001-40493 |
Entity Registrant Name | ATAI LIFE SCIENCES N.V. |
Entity Central Index Key | 0001840904 |
Entity Incorporation, State or Country Code | P7 |
Entity Tax Identification Number | 00-0000000 |
Entity Address, Address Line One | Wallstraße 16 |
Entity Address, City or Town | Berlin |
Entity Address, Country | DE |
Entity Address, Postal Zip Code | 10179 |
City Area Code | 49 89 |
Local Phone Number | 2153 9035 |
Title of 12(b) Security | Common shares, €0.10 par value per share |
Trading Symbol | ATAI |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
1 Year ATAI Life Sciences NV Chart |
1 Month ATAI Life Sciences NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions